Palisade Bio

About:

Palisade Bio is a clinical-stage biopharmaceutical company that develops therapies for acute and chronic gastrointestinal complications.

Website: https://www.palisadebio.com

Twitter/X: PalisadeBio

Top Investors: Yuma Regional Medical Center, Altium Capital

Description:

Palisade Bio is a clinical-stage biopharmaceutical company developing treatments for diseases of unmet medical need. They base these treatments on sound science and therapies with a decades-long history of safe and effective usage. The company's mission is to develop and commercialize novel therapeutics that target diseases resulting from a loss of gastrointestinal barrier integrity. The company was founded in 2011 and is headquartered in Carlsbad, California.

Total Funding Amount:

$59.4M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Carlsbad, California, United States

Founded Date:

2011-09-06

Contact Email:

info(AT)senecabio.com

Founders:

John Rodenrys

Number of Employees:

1-10

Last Funding Date:

2024-05-02

IPO Status:

Public

Industries:

© 2025 bioDAO.ai